Premium
Safety and Long‐Term Efficacy of Eculizumab in a Renal Transplant Patient with Recurrent Atypical Hemolytic–Uremic Syndrome
Author(s) -
Chatelet V.,
FrémeauxBacchi V.,
Lobbedez T.,
Ficheux M.,
Hurault de Ligny B.
Publication year - 2009
Publication title -
american journal of transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.89
H-Index - 188
eISSN - 1600-6143
pISSN - 1600-6135
DOI - 10.1111/j.1600-6143.2009.02817.x
Subject(s) - eculizumab , atypical hemolytic uremic syndrome , medicine , paroxysmal nocturnal hemoglobinuria , thrombotic microangiopathy , plasmapheresis , hemolytic anemia , gastroenterology , hemoglobinuria , immunology , complement system , hemolysis , antibody , disease